Physiologic and pathophysiologic consequences of altered sialylation and glycosylation on ion channel function

Biochemical and Biophysical Research Communications

Volumn 453, Issue 2, 2014, Pages 243-253

  Baycin Hizal, Deniz ^a   Gottschalk, Allan ^b   Jacobson, Elena ^a   Mai, Sunny ^a   Wolozny, Daniel ^a   Zhang, Hui ^a   Krag, Sharon S ^c   Betenbaugh, Michael J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Congenital disorders of glycosylation; Glycosylation; Neurological disorders; Sialylation; Voltage gated potassium channels; Voltage gated sodium channels

Indexed keywords

ION CHANNEL; SIALIC ACID; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL; N ACETYLNEURAMINIC ACID; POTASSIUM CHANNEL;

AGING; CONFORMATIONAL TRANSITION; CONGENITAL DISORDER OF GLYCOSYLATION; HUMAN; MOLECULAR PATHOLOGY; NEUROMUSCULAR DISEASE; NEURONAL CHANNELOPATHY; NONHUMAN; POLYSIALYLATION; REVIEW; SIALYLATION; ANIMAL; BIOLOGICAL MODEL; CHANNEL GATING; CHEMISTRY; GENETICS; GLYCOSYLATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MUTATION; PHYSIOLOGY;

AGING; ANIMALS; CONGENITAL DISORDERS OF GLYCOSYLATION; GLYCOSYLATION; GROWTH AND DEVELOPMENT; HUMANS; ION CHANNEL GATING; ION CHANNELS; MODELS, BIOLOGICAL; MUTATION; N-ACETYLNEURAMINIC ACID; POTASSIUM CHANNELS;

EID: 84908458737     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.06.067     Document Type: Review

References (103)

1. D.C. Gadsby Ion channels versus ion pumps: the principal difference, in principle Nat. Rev. Mol. Cell. Biol. 10 2009 344 352
2. T.A. Schwetz, S.A. Norring, and E.S. Bennett N-glycans modulate K(v)1.5 gating but have no effect on K(v)1.4 gating Biochim. Biophys. Acta 1798 2010 367 375
3. C.S. Jensen, H.B. Rasmussen, and H. Misonou Neuronal trafficking of voltage-gated potassium channels Mol. Cell. Neurosci. 2011
4. F. Tombola, M.M. Pathak, and E.Y. Isacoff How does voltage open an ion channel? Annu. Rev. Cell. Dev. Biol. 22 2006 23 52
5. M. Benatar Neurological potassium channelopathies QJM 93 2000 787 797
6. D. Johnson, and E.S. Bennett Gating of the shaker potassium channel is modulated differentially by N-glycosylation and sialic acids Pflugers Arch. 456 2008 393 405
7. I. Watanabe, H.G. Wang, J.J. Sutachan, J. Zhu, E. Recio-Pinto, and W.B. Thornhill Glycosylation affects rat Kv1.1 potassium channel gating by a combined surface potential and cooperative subunit interaction mechanism J. Physiol. 550 2003 51 66
8. J. Jaeken Congenital disorders of glycosylation (CDG): it's (nearly) all in it! J. Inherit. Metab. Dis. 34 2011 853 858
9. J. Jaeken Congenital disorders of glycosylation (CDG): update and new developments J. Inherit. Metab. Dis. 27 2004 423 426
10. D. Baycin-Hizal, Y. Tian, I. Akan, E. Jacobson, D. Clark, J. Chu, K. Palter, H. Zhang, and M.J. Betenbaugh GlycoFly: a database of Drosophila N-linked glycoproteins identified using SPEG-MS techniques J. Proteome Res. 10 2011 2777 2784
11. I. Watanabe, J. Zhu, J.J. Sutachan, A. Gottschalk, E. Recio-Pinto, and W.B. Thornhill The glycosylation state of Kv1.2 potassium channels affects trafficking, gating, and simulated action potentials Brain Res. 1144 2007 1 18
12. B.E. Ednie AR, Modulation of voltage-gated ion channels by sialylation, Compr. Physiol., 2 (2012) 1269-1301.
13. R.C. Ajit Varki, Jeffrey Esko, Hudson Freeze, Gerald Hart, and Jamey Marth, Essentials of Glycobiology, in: Sialic Acids, Cold Spring Harbor Laboratory Press, NY, 1999.
14. A. Varki Sialic acids as ligands in recognition phenomena FASEB J. 11 1997 248 255
15. S. Hinderlich, R. Stasche, R. Zeitler, and W. Reutter A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Purification and characterization of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase J. Biol. Chem. 272 1997 24313 24318
16. P.M. Berninsone, and C.B. Hirschberg Nucleotide sugar transporters of the Golgi apparatus Curr. Opin. Struct. Biol. 10 2000 542 547
17. K. Koles, E. Repnikova, G. Pavlova, L.I. Korochkin, and V.M. Panin Sialylation in protostomes: a perspective from Drosophila genetics and biochemistry Glycoconj. J. 26 2009 313 324
18. A. Irie, S. Koyama, Y. Kozutsumi, T. Kawasaki, and A. Suzuki The molecular basis for the absence of N-glycolylneuraminic acid in humans J. Biol. Chem. 273 1998 15866 15871
19. T. Angata, D. Nakata, T. Matsuda, K. Kitajima, and F.A. Troy 2nd Biosynthesis of KDN (2-keto-3-deoxy-D-glycero-D-galacto-nononic acid). Identification and characterization of a KDN-9-phosphate synthetase activity from trout testis J. Biol. Chem. 274 1999 22949 22956
20. E. Ong, J. Nakayama, K. Angata, L. Reyes, T. Katsuyama, Y. Arai, and M. Fukuda Developmental regulation of polysialic acid synthesis in mouse directed by two polysialyltransferases, PST and STX Glycobiology 8 1998 415 424
21. B.E. Close, K. Tao, and K.J. Colley Polysialyltransferase-1 autopolysialylation is not requisite for polysialylation of neural cell adhesion molecule J. Biol. Chem. 275 2000 4484 4491
22. D. Nakata, L. Zhang, and F.A. Troy 2nd Molecular basis for polysialylation: a novel polybasic polysialyltransferase domain (PSTD) of 32 amino acids unique to the alpha 2,8-polysialyltransferases is essential for polysialylation Glycoconj. J. 23 2006 423 436
23. M. Muhlenhoff, M. Eckhardt, and R. Gerardy-Schahn Polysialic acid: three-dimensional structure, biosynthesis and function Curr. Opin. Struct. Biol. 8 1998 558 564
24. A. Acheson, and U. Rutishauser Neural cell adhesion molecule regulates cell contact-mediated changes in choline acetyltransferase activity of embryonic chick sympathetic neurons J. Cell. Biol. 106 1988 479 486
25. U. Yabe, C. Sato, T. Matsuda, and K. Kitajima Polysialic acid in human milk. CD36 is a new member of mammalian polysialic acid-containing glycoprotein J. Biol. Chem. 278 2003 13875 13880
26. J. Ahrens, N. Foadi, A. Eberhardt, G. Haeseler, R. Dengler, A. Leffler, M. Muhlenhoff, R. Gerardy-Schahn, and M. Leuwer Defective polysialylation and sialylation induce opposite effects on gating of the skeletal Na channel NaV1.4 in Chinese hamster ovary cells Pharmacology 87 2011 311 317
27. G.A. Gutman, K.G. Chandy, S. Grissmer, M. Lazdunski, D. McKinnon, L.A. Pardo, G.A. Robertson, B. Rudy, M.C. Sanguinetti, W. Stuhmer, and X. Wang International Union of Pharmacology. LIII. nomenclature and molecular relationships of voltage-gated potassium channels Pharmacol. Rev. 57 2005 473 508
28. R. Lujan Organisation of potassium channels on the neuronal surface J. Chem. Neuroanat. 40 2010 1 20
29. H.A.a.H. AF, A quantitative description of membrane current and its application to conduction and excitation in nerve, J. Physiol, 117 (1952) 500-544.
30. R.G. Schwarz JR, Bostock H, Action potentials and membrane currents in the human node of Ranvier., Pflugers Arch, 430 (1995) 283-292.
31. M.C. Sanguinetti, and P.S. Spector Potassium channelopathies Neuropharmacology 36 1997 755 762
32. L.J. Ptacek Channelopathies: ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system Neuromuscul. Disord. 7 1997 250 255
33. F. Lehmann-Horn, and K. Jurkat-Rott Voltage-gated ion channels and hereditary disease Physiol. Rev. 79 1999 1317 1372
34. F. Weinreich, and T.J. Jentsch Neurological diseases caused by ion-channel mutations Curr. Opin. Neurobiol. 10 2000 409 415
35. W.B. Thornhill, M.B. Wu, X. Jiang, X. Wu, P.T. Morgan, and J.F. Margiotta Expression of Kv1.1 delayed rectifier potassium channels in Lec mutant Chinese hamster ovary cell lines reveals a role for sialidation in channel function J. Biol. Chem. 271 1996 19093 19098
36. N.P. Johnson, R. Kwok, A.W. Stewart, M. Saththianathan, W.E. Hadden, and L.W. Chamley Lipiodol fertility enhancement: two-year follow-up of a randomized trial suggests a transient benefit in endometriosis, but a sustained benefit in unexplained infertility Hum. Reprod. 22 2007 2857 2862
37. C.A. Ufret-Vincenty, D.J. Baro, and L.F. Santana Differential contribution of sialic acid to the function of repolarizing K(+) currents in ventricular myocytes Am. J. Physiol. Cell. Physiol. 281 2001 C464 C474
38. N.L. Brooks, M.J. Corey, and R.A. Schwalbe Characterization of N-glycosylation consensus sequences in the Kv3.1 channel FEBS J. 273 2006 3287 3300
39. T.A. Cartwright, M.J. Corey, and R.A. Schwalbe Complex oligosaccharides are N-linked to Kv3 voltage-gated K+ channels in rat brain Biochim. Biophys. Acta 1770 2007 666 671
40. K. Viswanathan, S. Lawrence, S. Hinderlich, K.J. Yarema, Y.C. Lee, and M.J. Betenbaugh Engineering sialic acid synthetic ability into insect cells: identifying metabolic bottlenecks and devising strategies to overcome them Biochemistry 42 2003 15215 15225
41. G. Shi, and J.S. Trimmer Differential asparagine-linked glycosylation of voltage-gated K+ channels in mammalian brain and in transfected cells J. Membr. Biol. 168 1999 265 273
42. T.A. Schwetz, S.A. Norring, A.R. Ednie, and E.S. Bennett Sialic acids attached to O-glycans modulate voltage-gated potassium channel gating J. Biol. Chem. 286 2011 4123 4132
43. J. Zhu, I. Watanabe, A. Poholek, M. Koss, B. Gomez, C. Yan, E. Recio-Pinto, and W.B. Thornhill Allowed N-glycosylation sites on the Kv1.2 potassium channel S1-S2 linker: implications for linker secondary structure and the glycosylation effect on channel function Biochem. J. 375 2003 769 775
44. J.J. Sutachan, I. Watanabe, J. Zhu, A. Gottschalk, E. Recio-Pinto, and W.B. Thornhill Effects of Kv1.1 channel glycosylation on C-type inactivation and simulated action potentials Brain Res. 1058 2005 30 43
45. J. Zhu, I. Watanabe, B. Gomez, and W.B. Thornhill Determinants involved in Kv1 potassium channel folding in the endoplasmic reticulum, glycosylation in the Golgi, and cell surface expression J. Biol. Chem. 276 2001 39419 39427
46. I. Utsunomiya, S. Tanabe, T. Terashi, S. Ikeno, T. Miyatake, K. Hoshi, and K. Taguchi Identification of amino acids in the pore region of Kv1.2 potassium channel that regulate its glycosylation and cell surface expression J. Neurochem. 112 2010 913 923
47. L. Santacruz-Toloza, Y. Huang, S.A. John, and D.M. Papazian Glycosylation of shaker potassium channel protein in insect cell culture and in Xenopus oocytes Biochemistry 33 1994 5607 5613
48. J. Zhu, E. Recio-Pinto, T. Hartwig, W. Sellers, J. Yan, and W.B. Thornhill The Kv1.2 potassium channel: the position of an N-glycan on the extracellular linkers affects its protein expression and function Brain Res. 1251 2009 16 29
49. M.K. Hall, T.A. Cartwright, C.M. Fleming, and R.A. Schwalbe Importance of glycosylation on function of a potassium channel in neuroblastoma cells PloS One 6 2011 e19317
50. P. Strop, A.J. Bankovich, K.C. Hansen, K.C. Garcia, and A.T. Brunger Structure of a human A-type potassium channel interacting protein DPPX, a member of the dipeptidyl aminopeptidase family J. Mol. Biol. 343 2004 1055 1065
51. K. McCormack, J.X. Connor, L. Zhou, L.L. Ho, B. Ganetzky, S.Y. Chiu, and A. Messing Genetic analysis of the mammalian K+ channel beta subunit Kvbeta 2 (Kcnab2) J. Biol. Chem. 277 2002 13219 13228
52. Y. Tian, and H. Zhang Glycoproteomics and clinical applications Proteomics Clin. Appl. 4 2010 124 132
53. H.H. Freeze, and M. Aebi Altered glycan structures: the molecular basis of congenital disorders of glycosylation Curr. Opin. Struct. Biol. 15 2005 490 498
54. B.G. Ng, V. Sharma, L. Sun, E. Loh, W. Hong, S.K. Tay, and H.H. Freeze Identification of the first COG-CDG patient of Indian origin Mol. Genet. Metab. 102 2011 364 367
55. E. Zagha, S. Manita, W.N. Ross, and B. Rudy Dendritic Kv3.3 potassium channels in cerebellar purkinje cells regulate generation and spatial dynamics of dendritic Ca2+ spikes J. Neurophysiol. 103 2010 3516 3525
56. S. Grunewald The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia) Biochim. Biophys. Acta 1792 2009 827 834
57. S. Kjaergaard, M. Schwartz, and F. Skovby Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype Arch. Dis. Childhood 85 2001 236 239
58. M. Al-Owain, S. Mohamed, N. Kaya, A. Zagal, G. Matthijs, and J. Jaeken A novel mutation and first report of dilated cardiomyopathy in ALG6-CDG (CDG-Ic): a case report Orphan. J. Rare Dis. 5 2010 7
59. T. Imbach, P. Burda, P. Kuhnert, R.A. Wevers, M. Aebi, E.G. Berger, and T. Hennet A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic Proc. Natl. Acad. Sci. U.S.A. 96 1999 6982 6987
60. C. Korner, R. Knauer, U. Stephani, T. Marquardt, L. Lehle, and K. von Figura Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase EMBO J. 18 1999 6816 6822
61. C. Kranz, L. Sun, E.A. Eklund, D. Krasnewich, J.R. Casey, and H.H. Freeze CDG-Id in two siblings with partially different phenotypes Am. J. Med. Genet. Part A 143a 2007 1414 1420
62. T. Imbach, B. Schenk, E. Schollen, P. Burda, A. Stutz, S. Grunewald, N.M. Bailie, M.D. King, J. Jaeken, G. Matthijs, E.G. Berger, M. Aebi, and T. Hennet Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie J. Clin. Invest. 105 2000 233 239
63. C. Kranz, J. Denecke, M.A. Lehrman, S. Ray, P. Kienz, G. Kreissel, D. Sagi, J. Peter-Katalinic, H.H. Freeze, T. Schmid, S. Jackowski-Dohrmann, E. Harms, and T. Marquardt A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If) J. Clin. Invest. 108 2001 1613 1619
64. C. Thiel, M. Schwarz, M. Hasilik, U. Grieben, F. Hanefeld, L. Lehle, K. von Figura, and C. Korner Deficiency of dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl mannosyltransferase causes congenital disorder of glycosylation type Ig Biochem. J. 367 2002 195 201
65. T. Stolting, H. Omran, A. Erlekotte, J. Denecke, J. Reunert, and T. Marquardt Novel ALG8 mutations expand the clinical spectrum of congenital disorder of glycosylation type Ih Mol. Genet. Metab. 98 2009 305 309
66. C. Thiel, M. Schwarz, J. Peng, M. Grzmil, M. Hasilik, T. Braulke, A. Kohlschutter, K. von Figura, L. Lehle, and C. Korner A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis J. Biol. Chem. 278 2003 22498 22505
67. X. Wu, J.S. Rush, D. Karaoglu, D. Krasnewich, M.S. Lubinsky, C.J. Waechter, R. Gilmore, and H.H. Freeze Deficiency of UDP-GlcNAc:Dolichol phosphate N-Acetylglucosamine-1 phosphate transferase (DPAGT1) causes a novel congenital disorder of glycosylation type Ij Hum. Mutat. 22 2003 144 150
68. M. Schwarz, C. Thiel, J. Lubbehusen, B. Dorland, T. de Koning, K. von Figura, L. Lehle, and C. Korner Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik Am. J. Hum. Genet. 74 2004 472 481
69. C.G. Frank, C.E. Grubenmann, W. Eyaid, E.G. Berger, M. Aebi, and T. Hennet Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL Am. J. Hum. Genet. 75 2004 146 150
70. C. Kranz, C. Jungeblut, J. Denecke, A. Erlekotte, C. Sohlbach, V. Debus, H.G. Kehl, E. Harms, A. Reith, S. Reichel, H. Grobe, G. Hammersen, U. Schwarzer, and T. Marquardt A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy Am. J. Hum. Genet. 80 2007 433 440
71. J. Jaeken, W. Vleugels, L. Regal, C. Corchia, N. Goemans, M.A. Haeuptle, F. Foulquier, T. Hennet, G. Matthijs, and C. Dionisi-Vici RFT1-CDG: deafness as a novel feature of congenital disorders of glycosylation J. Inherit. Metab. Dis. 32 Suppl. 1 2009 S335 S338
72. D.J. Lefeber, J. Schonberger, E. Morava, M. Guillard, K.M. Huyben, K. Verrijp, O. Grafakou, A. Evangeliou, F.W. Preijers, P. Manta, J. Yildiz, S. Grunewald, M. Spilioti, C. van den Elzen, D. Klein, D. Hess, H. Ashida, J. Hofsteenge, Y. Maeda, L. van den Heuvel, M. Lammens, L. Lehle, and R.A. Wevers Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies Am. J. Hum. Genet. 85 2009 76 86
73. N. Rind, V. Schmeiser, C. Thiel, B. Absmanner, J. Lubbehusen, J. Hocks, N. Apeshiotis, E. Wilichowski, L. Lehle, and C. Korner A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip Hum. Mol. Genet. 19 2010 1413 1424
74. V. Cantagrel, D.J. Lefeber, B.G. Ng, Z. Guan, J.L. Silhavy, S.L. Bielas, L. Lehle, H. Hombauer, M. Adamowicz, E. Swiezewska, A.P. De Brouwer, P. Blumel, J. Sykut-Cegielska, S. Houliston, D. Swistun, B.R. Ali, W.B. Dobyns, D. Babovic-Vuksanovic, H. van Bokhoven, R.A. Wevers, C.R. Raetz, H.H. Freeze, E. Morava, L. Al-Gazali, and J.G. Gleeson SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder Cell 142 2010 203 217
75. I. Martinez-Duncker, T. Dupre, V. Piller, F. Piller, J.J. Candelier, C. Trichet, G. Tchernia, R. Oriol, and R. Mollicone Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter Blood 105 2005 2671 2676
76. F. Foulquier, E. Vasile, E. Schollen, N. Callewaert, T. Raemaekers, D. Quelhas, J. Jaeken, P. Mills, B. Winchester, M. Krieger, W. Annaert, and G. Matthijs Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II Proc. Natl. Acad. Sci. U.S.A. 103 2006 3764 3769
77. C. Kranz, B.G. Ng, L. Sun, V. Sharma, E.A. Eklund, Y. Miura, D. Ungar, V. Lupashin, R.D. Winkel, J.F. Cipollo, C.E. Costello, E. Loh, W. Hong, and H.H. Freeze COG8 deficiency causes new congenital disorder of glycosylation type IIh Hum. Mol. Genet. 16 2007 731 741
78. F. Foulquier, D. Ungar, E. Reynders, R. Zeevaert, P. Mills, M.T. Garcia-Silva, P. Briones, B. Winchester, W. Morelle, M. Krieger, W. Annaert, and G. Matthijs A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation Hum. Mol. Genet. 16 2007 717 730
79. P. Paesold-Burda, C. Maag, H. Troxler, F. Foulquier, P. Kleinert, S. Schnabel, M. Baumgartner, and T. Hennet Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation Hum. Mol. Genet. 18 2009 4350 4356
80. E. Reynders, F. Foulquier, E. Leao Teles, D. Quelhas, W. Morelle, C. Rabouille, W. Annaert, and G. Matthijs Golgi function and dysfunction in the first COG4-deficient CDG type II patient Hum. Mol. Genet. 18 2009 3244 3256
81. M.A. Simpson, H. Cross, C. Proukakis, D.A. Priestman, D.C. Neville, G. Reinkensmeier, H. Wang, M. Wiznitzer, K. Gurtz, A. Verganelaki, A. Pryde, M.A. Patton, R.A. Dwek, T.D. Butters, F.M. Platt, and A.H. Crosby Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase Nat. Genet. 36 2004 1225 1229
82. J. Jaeken, H. Schachter, H. Carchon, P. De Cock, B. Coddeville, and G. Spik Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II Arch. Dis. Childhood 71 1994 123 127
83. J. Tan, J. Dunn, J. Jaeken, and H. Schachter Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development Am. J. Hum. Genet. 59 1996 810 817
84. P. de Cock, and J. Jaeken MGAT2 deficiency (CDG-IIa): the Life of J Biochim. Biophys. Acta 1792 2009 844 846
85. C.M. De Praeter, G.J. Gerwig, E. Bause, L.K. Nuytinck, J.F. Vliegenthart, W. Breuer, J.P. Kamerling, M.F. Espeel, J.J. Martin, A.M. De Paepe, N.W. Chan, G.A. Dacremont, and R.N. Van Coster A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency Am. J. Hum. Genet. 66 2000 1744 1756
86. C.C. Hellbusch, M. Sperandio, D. Frommhold, S. Yakubenia, M.K. Wild, D. Popovici, D. Vestweber, H.J. Grone, K. von Figura, T. Lubke, and C. Korner Golgi GDP-fucose transporter-deficient mice mimic congenital disorder of glycosylation IIc/leukocyte adhesion deficiency II J. Biol. Chem. 282 2007 10762 10772
87. B. Hansske, C. Thiel, T. Lubke, M. Hasilik, S. Honing, V. Peters, P.H. Heidemann, G.F. Hoffmann, E.G. Berger, K. von Figura, and C. Korner Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId J. Clin. Invest. 109 2002 725 733
88. X. Wu, R.A. Steet, O. Bohorov, J. Bakker, J. Newell, M. Krieger, L. Spaapen, S. Kornfeld, and H.H. Freeze Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder Nat. Med. 10 2004 518 523
89. H. B., Ion Channels of Excitable Membranes, 3 ed., Sinauer Associates, Sunderland, MA, 2001.
90. A.W. CA Remme, Targeting sodium channels in cardiac arrhythmia, Curr. Opin. Pharmacol., (2013) 53-60.
91. F.H. Yu, and W.A. Catterall Overview of the voltage-gated sodium channel family Genome Biol. 4 2003 1 7
92. S.P. Montpetit ML, Schwetz TA, Harper JM, Norring SA, Schaffer L, North SJ, Jang-Lee J, Gilmartin T, Head SR, Haslam SM, Dell A, Marth JD, Bennett ES., Regulated and aberrant glycosylation modulate cardiac electrical signaling., Proc. Natl. Acad. Sci. U.S.A., 106 (2009) 16517-16522.
93. P.J. Stocker, and E.S. Bennett Differential sialylation modulates voltage-gated Na+ channel gating throughout the developing myocardium J. Gen. Physiol. 127 2006 253 265
94. D. Johnson, and E.S. Bennett Isoform-specific effects of the B2 subunit on voltage-gated sodium channel gating J. Biol. Chem. 281 2006 25875 25881
95. E. Bennet, M. Urcan, S.S. Tinkle, A.G. Koszowski, and S.R. Levinson Contribution of Sialic Acid to the Voltage Dependence of Sodium Channel Gating J. Gen. Physiol. 109 1997
96. D. Johnson, M. Montpetit, P.J. Stocker, and E.S. Bennet The sialic acid component of the beta 1 subunit modulated voltage-gated sodium channel function J. Biol. Chem. 279 2004
97. H.K. Ednie AR, Wu J, Bennett ES, Expression of the sialyltransferase, ST3Gal4, impacts cardiac voltage-gated sodium channel activity, refractory period and ventricular conduction, J Mol Cell Cardiol, 59 (2013) 117-127.
98. I.E. Isaev D, Shatskih T, Zhao Q, Smits N, Shworak N, Khazipov R and Holmes G, Role of Extracellular Sialic Acid in Regulation of Neuronal and Network Excitability in the Rat Hippocampus, J. Neurosci., 27 (2007) 11587-11594.
99. L.I. Isaeva E, Savrasova A, Skibo G, Holmes GL, Isaev D., Effect of neuraminidase treatment on persistentepileptiform activity in the rat hippocampus, Pharmacol Rep., 63 (2011) 840-844.
100. W. Sg Acquired channelopathies in nerve injury and MS J. Neurobiol. 56 2001 1621 1627
101. M. Przybyło, and A. Lityńska Changes in glycosylation of rat liver arylsulfatase B in relation to age Mech. Ageing Dev. 113 2000 193 203
102. T.W. Castillo C, Zhu J, Recio-Pinto E, The Permeation and Activation Properties of Brain Sodium Channels Change during Development, Brain Res. Dev. Brain Res., 114 (2003) 99-106.
103. G.O. Knezevic A, Polasek O, Pucic M, Redzic I, Novokmet M, Rudd PM, Wright AF, Campbell H, Rudan I, Lauc G., Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-Glycans, Glycobiology, 20 (2010) 959-969.